FindTrial
Sign In

A medical records based study on the relationship between pathological subtypes and prognosis of early stage lung adenocarcinoma based on artificial intelligence radiomics and genomics

A study on the relationship between pathological subtypes and prognosis of early stage lung adenocarcinoma based on artificial intelligence radiomics and genomics

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2100043750
Enrollment
Unknown
Registered
2021-02-27
Start date
2021-03-01
Completion date
Unknown
Last updated
2021-06-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Lung Cancer

Interventions

Patients with early stage lung adenocarcinoma :gene test

Sponsors

Beijing Haidian Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: 1. Patients with lung adenocarcinoma who underwent complete resection; 2. Patients with stage I lung adenocarcinoma (T1N0M0, t2an0m0) after operation (the tumor staging was based on the TNM staging system published by the International Association for the study of lung cancer (IASLC) in 2017); 3. Patients with preoperative imaging data in the Department of radiology of our hospital; 4. Patients with ctDNA detection in peripheral blood before operation and gene detection in tissue samples after operation; 5. Effective follow-up, complete medical records and follow-up data.

Exclusion criteria

Exclusion criteria: 1. Patients with previous history of malignant tumor; 2. Patients with postoperative pathological type of small cell carcinoma or other types of non-small cell lung cancer; 3. Patients with postoperative pathological stage of stage II and stage III; 4. Patients died of complications during perioperative period; 5. Lost patients.

Design outcomes

Primary

MeasureTime frame
Relapse-free survival;recurrence rate;—

Countries

China

Contacts

Public ContactGuotian Pei

Beijing Haidian Hospital

pgtdoctor@163.com+86 1082693152

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026